Click on a filter below to refine your search. Remove a filter to broaden your search.
People with Medicare or Medicaid and those with private health insurance likely would get the vaccine for free.
In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine.
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025.
Pfizer also is working to improve its current COVID-19 vaccine “to address any future variant of potential concern, if needed.”
Under the law, Medicare will now be allowed to negotiate the cost of some drugs, and vaccines will be free for Part D recipients.
The updated vaccine is expected to have a “important role” in protecting people from COVID-19 this winter.
The new study will focus on a single omicron-specific booster dose in about 600 adults.
Sanofi plans to ramp up production of its version, but doctors should switch to the Tdap shot in the meantime.
Public health officials expect the demand for the new booster to surge in the next few weeks.
The FDA has added six weeks based on data from the company’s ongoing studies on the vaccine’s stability.